Radixin Knockdown by RNA Interference Suppresses Human Glioblastoma Cell Growth in Vitro and in Vivo |
Qin, Jun-Jie
(Department of Neuropathology, Beijing Neurosurgical Institute)
Wang, Jun-Mei (Department of Neuropathology, Beijing Neurosurgical Institute) Du, Jiang (Department of Neuropathology, Beijing Neurosurgical Institute) Zeng, Chun (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brain Tumors) Han, Wu (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brain Tumors) Li, Zhi-Dong (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brain Tumors) Xie, Jian (Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Brain Tumors) Li, Gui-Lin (Department of Neuropathology, Beijing Neurosurgical Institute) |
1 | Albini A, Iwamoto Y, Kleinman HK, et al (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 47, 3239-45. |
2 | Berx G, Staes K, van Henqel J, et al (1995). Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics, 26, 281-9. DOI ScienceOn |
3 | Bretscher A, Edwards K, Fehon RG (2002). ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol, 3, 586-99. |
4 | Butler WB, Berlinski PJ, Hillman RM, et al (1986). Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7. Cancer Res, 46, 6339-48. |
5 | Castle VP, Dixit VM, Polverini PJ (1997). Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells. Lab Invest, 77, 51-61. |
6 | Chen J, Xie F, Zhang L, et al (2010). iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway. BMC Cancer, 10, 694. DOI |
7 | Chen SD, Song MM, Zhong ZQ, et al (2012). Knockdown of radixin by RNA interference suppresses the growth of human pancreatic cancer cells in vitro and in vivo. Asian Pac J Cancer Prev, 13, 753-9. 과학기술학회마을 DOI |
8 | Cheng CL, Johnson SP, Keir ST, et al (2005). Poly (ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft. Mol Cancer Ther, 4, 1364-8. DOI |
9 | Curto M, McClatchey AI (2004). Ezrin a metastatic detERMinant? Cancer Cel, 5,113-4. DOI |
10 | Darakhshan S, Bidmeshkipour A, Khazaei M, et al (2013). Synergistic effects of tamoxifen and tranilast on VEGF and MMP-9 Regulation in cultured human breast cancer cells. Asian Pac J Cancer Prev, 14, 6869-74. 과학기술학회마을 DOI ScienceOn |
11 | Forsyth PA, Laing TD, Gibson AW, et al (1998). High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma. J Neurooncol, 36, 21-9. DOI |
12 | Forsyth PA, Wong H, Laing TD, et al (1999). Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer, 79, 1828-35. DOI |
13 | Frisch SM, Francis H (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol, 124, 619-26. DOI ScienceOn |
14 | Gautreau A, Louvard D, Arpin M (2002). ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. Curr Opin Cell Biol, 14, 104-9. DOI |
15 | Geiger KD, Stoldt P, Schlote W, et al (2000). Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol, 157, 1785-93. DOI ScienceOn |
16 | Hoeflich KP, Tsukita S, Hicks L, et al (2003). Insights into a single rod-like helix in activated radixin required for membranecytoskeletal cross-linking. Biochemistry, 42, 11634-41. DOI |
17 | Guo H, Ma Y, Zhang B, et al (2009). Pivotal advance: PKCzeta is required for migration of macrophages. J Leukoc Biol, 85, 911-8. DOI |
18 | Hanahan D, Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-64. DOI ScienceOn |
19 | Hoeflich KP, Ikura M (2004). Radixin: cytoskeletal adopter and signaling protein. Int J Biochem Cell Biol, 36, 2131-6. DOI |
20 | Hoffman S, Propp JM, McCarthy BJ (2006). Temporal trends in incidence of primary brain tumors in the United States, 1985- 1999. Neuro Oncol, 8, 27-37. DOI ScienceOn |
21 | Jimenez B, Volpert OV, Crawford SE, et al (2000). Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med, 6, 41-8. DOI ScienceOn |
22 | Jin J, Cai L, Liu ZM, et al (2013). miRNA-218 Inhibits Osteosarcoma Cell Migration and Invasion by Down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev, 14, 3681-4. 과학기술학회마을 DOI ScienceOn |
23 | Khanna C, Wan X, Bose S, et al (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med, 10, 182-6. DOI ScienceOn |
24 | Kidoikhammouan S, Seubwai W, Tantapotinan N, et al (2013). TNP-470, A methionine aminopeptidase-2 inhibitor, inhibits cell proliferation, migration and invasion of human cholangiocarcinoma Cells In Vitro. Asian Pac J Cancer Prev, 13, 155-60. |
25 | Liotta LA, Steeg PS, Stetler-Stevenson WG (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-36. DOI ScienceOn |
26 | Kikuchi S, Hata M, Fukumoto K, et al (2002). Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. Nat Gene, 31, 320-5. DOI |
27 | Kjaergaard J, Wang LX, Kuriyama H, et al (2005). Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines. J Neurosurg 103, 156-64. DOI |
28 | Lawler J, Miao WM, Duquette M, et al (2001). Thrombospondin-1 gene expression affects survival and tumor spectrum of p53- deficient mice. Am J Pathol, 159, 1949-56. DOI |
29 | McClatchey AI (2003). Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer, 3, 877-83. DOI ScienceOn |
30 | Meng Y, Lu Z, Yu S, et al (2010). Ezrin promotes invasion and metastasis of pancreatic cancer cells. J Transl Med, 8, 61. DOI |
31 | Moon Y, Bottone FGJr, McEntee MF, et al (2005). Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1. Mol Cancer Ther, 4, 1551-8. DOI ScienceOn |
32 | Nakada M, Nakada S, Demuth T, et al (2007). Molecular targets of glioma invasion. Cell Mol Life Sci, 64, 458-78. DOI ScienceOn |
33 | Ng SS, Cheung YT, An XM, et al (2007). Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma. J Natl Cancer Inst, 99, 936-48. DOI |
34 | Ramoni C, Luciani F, Spadaro F, et al (2002). Differential expression and distribution of ezrin, radixin and moesin in human natural killer cells. Eur J Immunol, 32, 3059-65. DOI |
35 | Ou-Yang M, Liu H R, Zhang Y, et al (2011). ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. Biochimie, 93, 954-61. DOI |
36 | Paglini G, Kunda P, Quiroga S, et al. (1998). Suppression of radixin and moesin alters growth cone morphology, motility, and process formation in primary cultured neurons. J Cell Biol, 143, 443-55. DOI |
37 | Persson A, Lindwall C, Curtis MA, et al (2010). Expression of ezrin radixin moesin proteins in the adult subventricular zone and the rostral migratory stream. Neuroscience, 167, 312-22. DOI |
38 | Revillion F, Lhotellier V, Hornez L, et al (2008). Real-time reversetranscription PCR to quantify a panel of 19 genes in breast cancer: relationships with sentinel lymph node invasion. Int J Biol Markers, 23, 10-7. |
39 | Schneider T, Mawrin C, Scherlach C, et al (2010). Gliomas in adults. Dtsch Arztebl Int, 107, 799-807. |
40 | Singh S, Sadanandam A, Varney ML, et al (2010). Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion. Int J Cancer, 126, 328-36. DOI |
41 | Stemmler MP (2008). Cadherins in development and cancer. Mol Biosyst, 4, 835-50. DOI ScienceOn |
42 | Stupp R, Hegi M E, van den Bent MJ, et al. (2006). Changing paradigms-an update on the multidisciplinary management of malignant glioma. Oncologist, 11, 165-80. DOI |
43 | Tsukita S, Yonemura S (1999). Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins. J Biol Chem, 274, 34507-10. DOI ScienceOn |
44 | Suda J, Zhu L, Karvar S (2011). Phosphorylation of radixin regulates cell polarity and Mrp-2 distribution in hepatocytes. Am J Physiol Cell Physiol, 300, 416-24. DOI |
45 | Sun XJ, Liu H, Zhang P, et al (2013). miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells. Asian Pac J Cancer Prev, 14, 5533-7. 과학기술학회마을 DOI ScienceOn |
46 | Takeichi M (1993). Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol, 5, 806-11. DOI ScienceOn |
47 | Turunen O, Wahlstrom T, Vaheri A (1994). Ezrin has a COOHterminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol, 126, 1445-53. DOI ScienceOn |
48 | Tynninen O, Carpen O, Jaaskelainen J, et al (2004). Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neurobiol, 30, 472-7. DOI ScienceOn |
49 | Uhm JH, Dooley NP, Villemure JG, et al (1997). Mechanisms of glioma invasion: role of matrix-metalloproteinases. Can J Neurol Sci, 24, 3-15. |
50 | van Roy F and Berx G (2008). The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci, 65, 3756-88. DOI ScienceOn |
51 | Wen PY, Yung WK, Lamborn KR, et al (2006). Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res, 12, 4899-907. DOI |
52 | Yahayo W, Supabpho A, Supabphol R (2013). Suppression of human fibrosarcoma cell metastasis by Phyllanthus emblica extract in Vitro. Asian Pac J Cancer Prev, 14, 6863-7. 과학기술학회마을 DOI ScienceOn |
53 | Xia H, Qi Y, Ng SS, et al (2009). microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res, 1269, 158-65. DOI |